Cambridge Investment Research Advisors Inc. acquired a new stake in shares of SIGA Technologies, Inc. (NASDAQ:SIGA – Get Rating) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 10,231 shares of the company’s stock, valued at approximately $105,000.
Several other institutional investors also recently bought and sold shares of the company. UBS Group AG boosted its stake in SIGA Technologies by 30.3% in the second quarter. UBS Group AG now owns 4,596 shares of the company’s stock valued at $53,000 after acquiring an additional 1,070 shares in the last quarter. Rhumbline Advisers lifted its stake in shares of SIGA Technologies by 6.8% during the second quarter. Rhumbline Advisers now owns 55,134 shares of the company’s stock worth $638,000 after buying an additional 3,531 shares during the period. Charles Schwab Investment Management Inc. lifted its stake in shares of SIGA Technologies by 3.1% during the first quarter. Charles Schwab Investment Management Inc. now owns 126,333 shares of the company’s stock worth $896,000 after buying an additional 3,804 shares during the period. Franklin Resources Inc. lifted its stake in shares of SIGA Technologies by 31.6% during the second quarter. Franklin Resources Inc. now owns 18,696 shares of the company’s stock worth $217,000 after buying an additional 4,493 shares during the period. Finally, Bank of New York Mellon Corp lifted its stake in shares of SIGA Technologies by 2.1% during the first quarter. Bank of New York Mellon Corp now owns 225,277 shares of the company’s stock worth $1,598,000 after buying an additional 4,555 shares during the period. 39.44% of the stock is currently owned by institutional investors and hedge funds.
SIGA Technologies Trading Up 4.2 %
NASDAQ:SIGA opened at $8.42 on Tuesday. SIGA Technologies, Inc. has a 12 month low of $5.84 and a 12 month high of $26.99. The firm has a fifty day simple moving average of $8.27 and a 200-day simple moving average of $12.05. The company has a market capitalization of $614.86 million, a P/E ratio of 5.81 and a beta of 0.78.
SIGA Technologies Profile
SIGA Technologies, Inc is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The firm develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses.
- Get a free copy of the StockNews.com research report on SIGA Technologies (SIGA)
- Michael Burry is Bearish on Stocks Again and Heres Why
- Don’t Miss These 2 Mid-Cap Techs That Broke Out Last Week
- Is Macau a Sinking Ship for Wynn Resorts?
- Pinterest is the Social Commerce Platform to Watch in 2023
- Is Walgreens Boots Alliance Earnings Miss Good For Investors?
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.